Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(17%)
Results Posted
100%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
2
33%
Ph early_phase_1
1
17%
Ph phase_1
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)
Other(1)

Detailed Status

Completed2
Active, not recruiting1
Suspended1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
66.7%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
N/A2 (50.0%)

Trials by Status

active_not_recruiting117%
suspended117%
terminated117%
completed233%
withdrawn117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
PROCEDURE
Total Trials
6